A research team at Mount Sinai has uncovered a previously unrecognized neural pathway that may help explain how stress contributes directly to elevated blood sugar levels—and ultimately, to type 2 diabetes. The study, published today in Nature Communications, reveals that the brain’s medial amygdala—a region typically associated with emotion—can activate glucose production in the liver, especially under conditions of repeated stress and poor diet.

A Stress-Activated Circuit from Emotion to Metabolism

For decades, scientists have focused on the hypothalamus and brainstem as the primary regulators of blood sugar. However, Mount Sinai investigators, including Dr. Sarah Stanley and Dr. Paul J. Kenny, developed an animal model that shows the medial amygdala plays a surprising and critical role in glycemic control.

In this study, mice subjected to various forms of acute stress—social, visual, and otherwise—showed a doubling of medial amygdala activity and a simultaneous 70% spike in blood sugar. Notably, the neural response predated the glucose surge, suggesting causation rather than correlation.

Turning on the Circuit—Even Without Stress

To test causality, researchers artificially activated neurons in the medial amygdala of unstressed mice. Within minutes, blood glucose climbed by about 50%, mirroring the stress response—without any behavioral signs of distress. This experiment bolstered the conclusion that medial amygdala activity drives glycemic response directly.

Mapping the pathway further, the team traced connections starting in the medial amygdala, passing through the hypothalamus, and ending in the liver. Selective activation of this circuit nearly doubled the amount of glucose released by the liver into the bloodstream.

Sign up for the Daily Dose Newsletter and get every morning’s best science news from around the web delivered straight to your inbox? It’s easy like Sunday morning.

Stress, Diet, and Long-Term Disruption

Alarmingly, when mice were exposed to chronic stress combined with a fatty diet, the neural circuit became desensitized. Subsequent stressors elicited a weaker neurological response but led to persistently elevated blood glucose levels, even when stress exposure ended. This suggests that prolonged activation of this pathway may rewire how the system responds, nudging the organism toward a diabetic state.

Implications for Preventative Medicine

These findings could profoundly shift how clinicians approach stress and metabolic disease. By identifying a concrete brain-to-liver circuit, the research offers a potential new target for therapies aimed at reducing diabetes risk—or improving glucose control in already diabetic patients under stress.

Dr. Stanley commented, “The results of this study not only change how we think about the role of stress in diabetes, but also how we think about the role of the amygdala. Previously, we thought the amygdala only controls our behavioral response to stress—now, we know it controls bodily responses, too.” She added that addressing societal stressors may yield broader health benefits.

Looking Ahead: Unraveling the Circuit’s Complexities

The researchers emphasized the need for further investigation—particularly into the cellular specifics of the pathway, as well as how stress duration and intensity reshape these neural circuits and gene expression. There’s also interest in exploring whether reducing stress can reverse the circuit’s disruption and restore healthy glucose regulation.